m+Medelevator.RU
← Поиск публикаций
Veterinary microbiology · 2026

Activating FcγRI inhibits RIG-I-mediated host antiviral innate immunity by FGR during PRRSV-ADE infection.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Xu Peng-Li, Li Yi-Han, Li Fa-Hao, Zhao Shi-Jie, Li Wen, Chen Jing, Xia Ping-An, Zhang Yi-Na

Аннотация

Currently, the antibody-dependent enhancement (ADE) effect has been a pivotal factor in the persistent infection of pigs with porcine reproductive and respiratory syndrome virus (PRRSV) and a major hurdle in developing safe and effective vaccines. Therefore, elucidating the molecular mechanisms of ADE in PRRSV infection is crucial. This study assessed the impact of Fc gamma receptor I (FcγRI), Fc epsilon receptor gamma chain (FCER1G), and FGR on the host's antiviral innate immune response during PRRSV-ADE infection in vitro. Our results revealed that the expressions of RIG-I, TBK-1, IRF-3, STAT-1, and STAT-2 were markedly inhibited in porcine alveolar macrophages (PAMs) via ADE. Furthermore, the production of IFN-α, ISG15, ISG56, OAS1, OAS2, Mx1, and RSAD2 were dramatically decreased during PRRSV-ADE infection. Additionally, gene knockdown studies indicated that PRRSV-ADE infection upregulates FGR expression by activating FcγRI. Moreover, knocking down endogenous FcγRI, FCER1G, or FGR alleviated the inhibitory effect of PRRSV-ADE infection on the RIG-I-mediated antiviral innate immune response in PAMs. Thus, our findings demonstrate that activation FcγRI could suppress RIG-I-mediated antiviral innate immune response through FGR during PRRSV-ADE infection, thereby facilitating viral replication. These insights enhance our understanding of the molecular mechanism of underlying intrinsic ADE (iADE) and could contribute to the design of novel PRRSV vaccine.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты